Fluvastatin in familial hypercholesterolemia: A cohort analysis of the response to combination treatment

The American Journal of Cardiology

Volumn 73, Issue 14, 1994, Pages

  Muratti, Eleonora N ^b   Peters, Tim K ^b   Leitersdorf, Eran ^a  

^a The Diabetes Research Center   (Israel)

^b Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BEZAFIBRATE; COLESTYRAMINE; CREATINE KINASE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS;

ADULT; ANALYSIS OF VARIANCE; ANTICHOLESTEREMIC AGENTS; BEZAFIBRATE; CHOLESTYRAMINE; COHORT STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FATTY ACIDS, MONOUNSATURATED; FEMALE; HETEROZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; INDOLES; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0028200060     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(94)90630-0     Document Type: Article

References (26)

1. Combination therapy for familial combined hyperlipidemia
2. Combination drug therapy in the treatment of severe hyperlipidaemia
3. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
4. Intensive combination drug therapy for familial hypercholesterolemia with lovastatin, probucol and colestipol hydrochloride
5. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia
6. Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemia
7. Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia
8. Tolerability and efficacy of combination therapy with simvastatin plus gemfibrozil in type IIb refractory familial combined hyperlipidemia
9. Addition of fibrates to simvastatin therapy in hyperlipidaemic patients
10. Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density lipoprotein triglycerides
11. Adverse effects of drugs on muscle
12. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy
13. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis to a fluvastatin-cholestyramine combination
14. Differential response of plasma cholesterol to fluvastatin, a new HMG CoA reductase inhibitor, in three groups of genetically defined heterozygote patients with familial hypercholesterolemia
15. Efficacy and safety of high dose of fluvastatin in patients with FH
16. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
17. Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia
18. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM
19. The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia
20. Treatment of primary hypercholesterolemia with simvastatin: New Zealand multicenter evaluation
21. The hypolipidaemic effects of pravastatin (CS-514) alone and in combination with bezafibrate or acipimox in patients with primary hypercholesterolaemia
22. Effects of combined bezafibrate-simvastatin appraised in healthy subjects
23. Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias
24. A retrospective review of the use of lipid-lowering agents in combination, specifically, gemfibrozil and lovastatin
25. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia
26. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination